Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers

Jordi Rello, Enrico Storti, Mirko Belliato, Ricardo Serrano

Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020
Journal Issue: May
Disease area: Respiratory critical care

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jordi Rello, Enrico Storti, Mirko Belliato, Ricardo Serrano. Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers. Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Clinical asthma phenotypes in the real world: opportunities and challenges
Source: Breathe 2015; 11:186-193
Year: 2015

Clinical implications
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007

Opportunities and outstanding challenges for integration in clinical practice
Source: Virtual Congress 2021 – Inhale the future: ambulatory sensing technologies, digital biomarkers and explainable insights
Year: 2021

Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008

The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018

Distinct clinical phenotypes of airways disease: a primary-care clinician perspective
Source: Eur Respir J 2010; 35: 459
Year: 2010

Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007

Common pitfalls in planning and conducting epidemiological and clinical research
Source: Annual Congress 2008 - PG10 - Getting it right – planning, realising, analysing and publishing research projects
Year: 2008

Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019

Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008

Variation among spirometry interpretation algorithms: Clinical implications
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010

Clinical phenotyping: role in treatment decisions in sarcoidosis
Source: Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019
Year: 2020

A critical evaluation of the relevance of different asthma phenotypes for clinical practice
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008

Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018

Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point
Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD
Year: 2008

Implications of the exposome and its applicability in clinical and epidemiological studies
Source: International Congress 2016 – Genetics, epigenetics and the exposome
Year: 2016

Future of eHealth in TB management: perspectives of patients and medical staff
Source: Virtual Congress 2021 – Digital innovations in tuberculosis and implementation research in the era of COVID-19: collaborative activities between the WHO and ERS
Year: 2021